Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 614 of 6351
-
Experimental drug aims to shield ICU patients from deadly infections
Disease control Recruiting nowThe goal of this clinical trial is to demonstrate the benefit of a standardized immunotherapy (Interferon gamma) on the incidence of secondary infections. . It will also learn about the safety of Interferon-gamma. The main questions it aims to answer are: Does Interferon-gamma: …
Phase 3 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a smarter pacemaker ease a common type of heart failure?
Disease control Recruiting nowELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart failure with…
Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New psoriasis pill zasocitinib takes on deucravacitinib in Head-to-Head trial
Disease control CompletedThe main aim of this study is to assess whether zasocitinib works better than deucravacitinib in treating participants with moderate-to-severe plaque psoriasis. Participants will take one tablet daily of either zasocitinib or a matching placebo, along with one capsule daily of e…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Experimental drug GLM101 targets rare PMM2-CDG in pivotal trial
Disease control OngoingThis study is evaluating the safety, effectiveness, and how the body absorbs, distributes, and eliminates GLM101, for participants with PMM2-CDG, including children, adolescents, and adults. Researchers will compare participants receiving GLM101 to those receiving a placebo to se…
Phase 2/3 • Sponsor: Glycomine, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Head-to-Head: which migraine pill works best?
Disease control Recruiting nowThis goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better…
Phase 4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Clot removal after heart attack: could it save lives?
Disease control Recruiting nowThe goal of this clinical trial is to determine whether manually removing a visible blood clot before percutaneous coronary intervention (PCI) improves outcomes in patients with ST-segment elevation myocardial infarction (STEMI). About 3500 patients who present within 24 hours of…
Sponsor: Shenghua Zhou • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
Could a drug combo replace chemo and transplant for multiple myeloma?
Disease control Recruiting nowThis study is designed as a multicenter, randomized, parallel groups, open-label, phase 3 study in subjects with untreated newly diagnoses Multiple Myeloma eligible for ASCT. 824 patients will be enrolled in this study from approximately 70 study sites. The 2 parts in the Treat…
Phase 3 • Sponsor: Intergroupe Francophone du Myelome • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Sound waves aimed at the brain could quiet seizures
Disease control Recruiting nowThe goal of this study is to investigate the effects of a non-invasive, low intensity focused ultrasound (LIFU) stimulation on seizure frequency and the epileptogenic network in drug-resistant epilepsy. LIFU uses focused sound waves to modulate deep brain regions and to enable ch…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThe study is being conducted to evaluate the safety, tolerability and efficacy of SHR-4849 injection combined with other antitumor drugs in patients with malignant solid tumors.
Phase 2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New vaccine against rift valley fever shows promise in early trial
Vaccine OngoingThe goal of this clinical trial is to learn if ChAdOx1 RVF, a candidate vaccine against RVF, provides an adequate immune response and determine its safety among Kenyan adults. The main aims are: * To assess the proportion of individuals mounting an immune response following vacc…
Phase 2 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Jun 27, 2026 07:57 UTC
-
Can a daily pill tame the painful lesions of hidradenitis suppurativa?
Disease control Recruiting nowThis study is a Phase Ic/II clinical trial conducted in Chinese patients with moderate-to-severe hidradenitis suppurativa (HS), aiming to evaluate the safety and efficacy of LT-002-158 tablets in the treatment of moderate-to-severe HS. The study consists of two parts. The Phase …
Phase 1/2 • Sponsor: Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could this vaccine stop future coronavirus pandemics?
Vaccine OngoingCoronaviruses (CoVs) have caused the severe acute respiratory syndrome (SARS) outbreak, the Middle East Respiratory Syndrome (MERS) outbreak, and now the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Although there are several approved or authorized vacci…
Phase 1 • Sponsor: Duke University • Aim: Vaccine
Last updated Jun 27, 2026 12:06 UTC
-
New COVID-19 vaccine trial targets High-Risk groups
Vaccine CompletedThe purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19. This study is seeking participants 12 through 64 years of age who are considered to be at higher risk for severe COVID-19 disease per study protocol a…
Phase 3 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
Lung cancer hope: new combo aims to stop tumor growth
Disease control Recruiting nowThis is an open-label, phase II, multi-centre clinical trial. 97 Patients with stage IIIA and IIIB non-small cell lung cancer will be enrolled. The treatment is Atezolizumab + Paclitaxel + Carboplatin 3 cycles as neoadjuvant/induction treatment. After the induction treatment eve…
Phase 2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for High-Risk prostate cancer: which targeted radiation works best?
Disease control Recruiting nowThere is evidence that Actinium-225 Prostate-Specific Membrane Antigen (225Ac-PSMA) has a potentially higher level of efficacy than 177 Lutetium Prostate-Specific Membrane Antigen (177Lu-PSMA) as a radioligand therapy. This single center, pilot study will compare differences in t…
Phase 1 • Sponsor: Thomas Hope • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowBackground: Mesothelioma is an aggressive cancer that grows in the linings of the body; this can include the membranes that line the heart, lungs, and internal organs. Mesothelin (MSLN) is a protein that appears in high numbers in many tumors, including mesothelioma. Researchers…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Engineered immune cells take on tough leukemia in kids
Disease control Recruiting nowThe goal of this clinical trial is to test the feasibility and safety of an academic production of two different anti-CD19 chimeric antigen receptor T cells (CART) products according to the different biomarkers of the disease in children and young adults with relapsed/refractory …
Phase 1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New vaccine targets rare liver cancer's genetic flaw
Vaccine Recruiting nowThe aim of this clinical trial is to evaluate the immunogenicity along with safety and toxicity as well as first efficacy of a DNAJB1-PRKACA fusion transcript-based peptide vaccine (Fusion-VAC-XS15) in patients with FL-HCC or other cancer entities carrying the DNAJB1-PRKACA fusio…
Phase 1 • Sponsor: University Hospital Tuebingen • Aim: Vaccine
Last updated Jun 27, 2026 09:04 UTC
-
Can a VR goggle tour of the operating room calm nerves before surgery?
Symptom relief CompletedThis study evaluated the effect of an operating room introduction using virtual reality (VR) on anxiety, surgical fear, patient satisfaction, postoperative pain, and physiological parameters in patients undergoing arthroscopic orthopedic surgery. The intervention consisted of a …
Sponsor: Acibadem University • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Booster shot study aims to keep teens safe from meningitis b
Vaccine CompletedThe main purpose of this study is to evaluate the immune response and safety of a booster dose of the meningococcal group B vaccine, rMenB+OMV NZ (also known as Bexsero), in adolescents and young adults aged 10 to 20 years. This study focuses on individuals who were first vaccina…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC